Treatment of vocal fold scarring with autologous bone marrow-derived human mesenchymal stromal cells—first phase I/II human clinical study

Por Stellan Hertegård, Srinivasa Rau Nagubothu, Emma Malmström, Katarina LeBlanc
Publicado em 2020-03-01

MSCs: Scientific Support for Multiple Therapies

Por Mark F. Pittenger, Katarina Le Blanc, Donald G. Phinney, Jerry K. Y. Chan
Publicado em 2015-01-01

Targeted Intra-arterial Transplantation of Stem Cells to the Injured CNS is more Effective than Intravenous Administration: Engraftment is Dependent on Cell Type and Adhesion Molec...

Por Johan Lundberg, Erik Södersten, Erik Sundström, Katarina Le Blanc, Tommy Andersson, Ola Hermanson, Staffan Holmin M.D., Ph.D.
Publicado em 2012-02-01

Adenovirus serotype 5 vectors with Tat-PTD modified hexon and serotype 35 fiber show greatly enhanced transduction capacity of primary cell cultures.

Por Di Yu, Chuan Jin, Mohanraj Ramachandran, Jing Xu, Berith Nilsson, Olle Korsgren, Katarina Le Blanc, Lene Uhrbom, Karin Forsberg-Nilsson, Bengt Westermark, Rachel Adamson, Norman Maitland, Xiaolong Fan, Magnus Essand
Publicado em 2013-01-01

Do ABO blood group antigens hamper the therapeutic efficacy of mesenchymal stromal cells?

Por Guido Moll, Annika Hult, Lena von Bahr, Jessica J Alm, Nina Heldring, Osama A Hamad, Lillemor Stenbeck-Funke, Stella Larsson, Yuji Teramura, Helene Roelofs, Bo Nilsson, Willem E Fibbe, Martin L Olsson, Katarina Le Blanc
Publicado em 2014-01-01